Literature DB >> 21815968

Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease.

S-R Nandula1, Y M Scindia, P Dey, H Bagavant, U S Deshmukh.   

Abstract

OBJECTIVE: Sjögren's syndrome is a chronic autoimmune disorder characterized by progressive lymphocytic infiltration within the salivary and lacrimal glands. This study was undertaken to investigate the effects of innate immunity activation on sialoadenitis in a mouse strain genetically susceptible for development of SS-like disease.
METHODS: Female New Zealand Black X New Zealand White F1 mice were repeatedly treated with toll-like 3 receptor agonist poly(I:C). Submandibular glands were investigated at different time points for sialoadenitis by immunohistochemistry and for gene expression of different chemokines by quantitative PCR. Submandibular gland-infiltrating cells were characterized by flow cytometry.
RESULTS: Poly(I:C) treatment significantly upregulated the expression of multiple chemokines within the submandibular glands. The severity and incidence of sialoadenitis was considerably higher in poly(I:C)-treated mice. There was a preponderance of dendritic cells and NK cells in the initial inflammatory cell infiltrates, and these were followed by CD4+ T cells.
CONCLUSIONS: Our data clearly demonstrate that systemic activation of innate immunity accelerates sialoadenitis in a mouse model for SS-like disease. These findings suggest that chronic activation of innate immunity can influence certain features of SS.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21815968      PMCID: PMC3192939          DOI: 10.1111/j.1601-0825.2011.01839.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  30 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Chemokine-chemokine receptor network in immune cell trafficking.

Authors:  Chang H Kim
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2004-12

3.  Immunohistochemical characterization of sialadenitis in NZB X NZW F1 mice.

Authors:  R Jonsson; A Tarkowski; K Bäckman; L Klareskog
Journal:  Clin Immunol Immunopathol       Date:  1987-01

4.  A laboratory model for Sjögren's syndrome.

Authors:  H S Kessler
Journal:  Am J Pathol       Date:  1968-03       Impact factor: 4.307

5.  Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.

Authors:  Prashant S Patole; Hermann-Josef Gröne; Stephan Segerer; Raluca Ciubar; Emilia Belemezova; Anna Henger; Matthias Kretzler; Detlef Schlöndorff; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2005-03-16       Impact factor: 10.121

6.  Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide.

Authors:  Hiroaki Moriyama; Li Wen; Norio Abiru; Edwin Liu; Liping Yu; Dongmei Miao; Roberto Gianani; F Susan Wong; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-09       Impact factor: 11.205

7.  Inhibitory effects of autoantibodies on the muscarinic receptors in Sjögren's syndrome.

Authors:  Jingchao Li; Young-Min Ha; Na-Youn Kü; Se-Young Choi; Sung J Lee; Seog B Oh; Joong-Soo Kim; Jong-Ho Lee; Eun B Lee; Yeong W Song; Kyungpyo Park
Journal:  Lab Invest       Date:  2004-11       Impact factor: 5.662

8.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Takashi Natsukawa; Noriaki Shinobu; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Shizuo Akira; Takashi Fujita
Journal:  Nat Immunol       Date:  2004-06-20       Impact factor: 25.606

9.  Poly I:C induces development of diabetes mellitus in BB rat.

Authors:  D O Sobel; J Newsome; C H Ewel; J A Bellanti; V Abbassi; K Creswell; O Blair
Journal:  Diabetes       Date:  1992-04       Impact factor: 9.461

10.  The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid.

Authors:  A D Steinberg; S Baron; N Talal
Journal:  Proc Natl Acad Sci U S A       Date:  1969-08       Impact factor: 11.205

View more
  32 in total

1.  When killers become helpers.

Authors:  Umesh S Deshmukh; Harini Bagavant
Journal:  Sci Transl Med       Date:  2013-07-24       Impact factor: 17.956

2.  Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands.

Authors:  Nathaniel M Green; Krishna-Sulayman Moody; Michelle Debatis; Ann Marshak-Rothstein
Journal:  J Biol Chem       Date:  2012-09-27       Impact factor: 5.157

3.  Interaction between innate immunity and Ro52-induced antibody causes Sjögren's syndrome-like disorder in mice.

Authors:  Barbara M Szczerba; Paulina Kaplonek; Nina Wolska; Anna Podsiadlowska; Paulina D Rybakowska; Paromita Dey; Astrid Rasmussen; Kiely Grundahl; Kimberly S Hefner; Donald U Stone; Stephen Young; David M Lewis; Lida Radfar; R Hal Scofield; Kathy L Sivils; Harini Bagavant; Umesh S Deshmukh
Journal:  Ann Rheum Dis       Date:  2015-02-05       Impact factor: 19.103

Review 4.  The NZB/W F1 mouse model for Sjögren's syndrome: A historical perspective and lessons learned.

Authors:  Harini Bagavant; Aleksandra Michrowska; Umesh S Deshmukh
Journal:  Autoimmun Rev       Date:  2020-10-22       Impact factor: 9.754

5.  Natural killer cells regulate murine cytomegalovirus-induced sialadenitis and salivary gland disease.

Authors:  Virginia A Carroll; Alyssa Lundgren; Hairong Wei; Susan Sainz; Kenneth S Tung; Michael G Brown
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

Review 6.  Advances in understanding the pathogenesis of primary Sjögren's syndrome.

Authors:  Gaëtane Nocturne; Xavier Mariette
Journal:  Nat Rev Rheumatol       Date:  2013-07-16       Impact factor: 20.543

7.  Toll-like receptor 3 stimulation promotes Ro52/TRIM21 synthesis and nuclear redistribution in salivary gland epithelial cells, partially via type I interferon pathway.

Authors:  N C Kyriakidis; E K Kapsogeorgou; V C Gourzi; O D Konsta; G E Baltatzis; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

8.  Type I interferon receptor deficiency prevents murine Sjogren's syndrome.

Authors:  B M Szczerba; P D Rybakowska; P Dey; K M Payerhin; A B Peck; H Bagavant; U S Deshmukh
Journal:  J Dent Res       Date:  2013-03-26       Impact factor: 6.116

9.  Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.

Authors:  Jing Zhou; Jun-O Jin; Juan Du; Qing Yu
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

Review 10.  Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.

Authors:  Marieke Robinet; Solène Maillard; Mélanie A Cron; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.